Phase II study of osimertinib in patients with plasma EGFR T790M positive advanced lung cancer (WJOG8815L/LPS)

Takayuki Takahama, Koichi Azuma, Mototsugu Shimokawa, Terufumi Kato, Haruko Daga, Isamu Okamoto, Hiroaki Akamatsu, Toshiaki Takahashi, Tatsuo Ohira, Toshihide Yokoyama, Katsuya Hirano, Yoshimasa Shiraishi, Daisuke Himeji, Nobuyuki Yamamoto, Kazuto Nishio, Kazuhiko Nakagawa

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)vii50
JournalAnnals of Oncology
Volume29
DOIs
Publication statusPublished - Oct 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this